glp-1 for binge eating The Ozempic Era and Disorders — Baltimore Therapy Group GLP-1 for Binge Eating Disorder:

As many as 3050% of depressed patients respond only partially to antidepressants, leaving them with substantial residual symptoms (Davis et al., 2021)

Growing evidence shows that in people with chronic kidney disease and type 2 diabetes, semaglutide reduces the risk of kidney function loss, kidney failure, cardiovascular events, cardiovascular death, and all-cause mortality

Acute kidney injury has occurred in patients experiencing severe vomiting, diarrhea, and dehydration

Additionally, Boca Medical Care emphasizes that Semaglutide GLP-1 should be used in conjunction with a balanced diet and regular physical activity for the best results in weight loss